Trimetazidine tablets p/o 20mg №10×3

Name Trimetazidine Belmed. Forms of release Tablets. MNN Trimetazidine. FTGAntihypoxic agent. What this drug is and what it is used for This drug is used in adult patients to treat angina pectoris (chest pain caused by coronary artery disease) in combination with other drugs. Do not take this medicine if • you are allergic to trimetazidine or any of the other ingredients of this medicine (see section Composition); • you have Parkinson’s disease: a brain disorder that causes movement problems (trembling, stiffness, slowing and shuffling, gait disturbance); • you have severe kidney disease; • You are pregnant or breastfeeding. If any of the above apply to you, tell your doctor. Special instructions and precautions: Talk to your doctor before taking Trimetazidine. This drug is not intended for the relief of angina attacks, and also as an initial treatment for unstable angina. This drug is not used to treat myocardial infarction. In the event of an attack of angina pectoris, inform your doctor about it. Examinations may be prescribed for you, and treatment may be adjusted. If you are in any doubt, ask your doctor or pharmacist for advice. This drug may cause or worsen symptoms such as trembling, stiffness, gait disturbance, slowness of movement and shuffling, especially in elderly patients, which should be monitored and reported to the doctor, who may re-evaluate the treatment. Drops may also be observed, which may be due to a decrease in pressure or loss of balance (see section 4). TRIMETAZIDINE contains lactose monohydrate. If you have an intolerance to some sugars, call your doctor before taking this drug. Children and adolescents Trimetazidine is not recommended for children under 18 years of age. Other drugs Tell your doctor, pharmacist or nurse if you are taking, have recently taken or may have taken any other medicines. No interactions with other medications have been noted. Taking Trimetazidine with food and drink Trimetazidine can be taken with food and drink. Pregnancy, breast-feeding and fertility If you are pregnant or breast-feeding, think you may be pregnant or are planning to become pregnant, consult your doctor before using this medicine. It is preferable not to take this drug during pregnancy. If during the time of taking the drug it turns out that you are pregnant, you should consult your doctor, as only he can judge the need to continue your treatment. Due to the lack of data on the release of the drug into breast milk, breastfeeding is not recommended during treatment with Trimetazidine. Driving vehicles and working with mechanisms During treatment, it is not recommended to drive vehicles and work with complex mechanisms that require increased concentration of attention and high speed of reactions, since TRIMETAZIDINE can cause dizziness and drowsiness. How to take this medicine Follow all instructions given to you by your doctor or nurse. Check with your doctor or nurse if you need more information. The recommended dose is 20 mg (1 tablet) 3 times a day. If you have kidney problems or are over 75 years of age, your doctor may adjust the recommended dose. Trimetazidine in combination with food and drink Trimetazidine may be taken with food and drink. If you forget to take TRIMETAZIDINE If you forget to take a medicine, take your next dose at the usual time. Do not double the next dose to replace the forgotten dose. If you have taken more TRIMETAZIDINE than you have been advised If you have taken too many tablets, contact your doctor immediately. If you stop taking TRIMETAZIDINE Your doctor will tell you how long to continue treatment. You should talk to your doctor before stopping this drug. If you have any further questions about the use of this medicine, ask your doctor, pharmacist or nurse. Method of application The drug is used orally, swallowing the tablet whole and drinking a glass of water with meals. Possible side effects Like all medicines, TRIMETAZIDINE can cause side effects, although not everyone gets them. Some adverse reactions may be serious. • Common (may affect more than 1 in 100 people): Dizziness, headache, abdominal pain, diarrhoea, dyspepsia, nausea, vomiting, rash, itching, hives and feeling weak. • Rare (may affect up to 1 in 10,000 people): Fast or irregular heartbeat (also called fluttering), extra heart beats, fast heartbeat, drop in blood pressure when standing up (which may be accompanied by dizziness), lightheadedness or fainting, malaise (general feeling of ill health), dizziness, falls, flushing of the face. • Not known (frequency cannot be estimated from the available data): Extrapyramidal symptoms (unusual movements, including trembling and shaking of the hands and fingers, undulations in the body, shuffling gait, and stiffness of the arms and legs), usually reversible upon discontinuation of treatment. Vertigo (sensation of rotation of surrounding objects). Sleep disturbances (difficulty falling asleep, drowsiness), constipation, severe generalized red skin rash with blistering, swelling of the face, lips, mouth, tongue or throat, which may cause difficulty swallowing or breathing. A severe decrease in the number of white blood cells in the blood, which makes infection more likely, a decrease in platelets, which increases the risk of bleeding and bruising. Liver disease (nausea, vomiting, loss of appetite, general feeling of illness, fever, itching, yellowing of the skin and eyes, light-colored feces, dark-colored urine). Reporting adverse reactions If you experience any adverse reactions, talk to your doctor or pharmacist. This recommendation applies to any possible adverse reactions, including those not listed in the package insert. You can also report adverse reactions to the information database on adverse reactions (actions) to drugs, including reports of drug inefficiency (UE Center for Expertise and Testing in Healthcare, rceth.by). By reporting adverse reactions, you help to get more information about the safety of the drug. Storage of the drug Keep the drug out of the reach of children. Store the drug in a place protected from moisture and light at a temperature not exceeding 25 ° C. Keep the drug in its original packaging. Shelf life – 3 years. Do not use the drug after the expiration date indicated on the package. The expiry date is the last day of the month. Do not use the drug if you notice that the cell in which the tablet is located is damaged. Do not dispose of the drug down the drain. Ask your pharmacist how to dispose of drugs you no longer need. These measures will help protect the environment. The active substance of the drug Trimetazidine is trimetazidine dihydrochloride 20 mg. Excipients: potato starch, calcium stearate, lactose monohydrate, shell (hypromellose 2910, polysorbate 80, titanium dioxide, talc). Appearance of the drug and the contents of the package TRIMETAZIDINE – biconvex tablets, film-coated white. On the surface of the tablets, the unevenness of the film coating is allowed. 10 tablets in a blister pack made of PVC film and aluminum foil. Three blister packs, together with a leaflet, are placed in a pack of cardboard. Leave conditions By prescription. Buy Trimetazidine tablets p/o 20mg No. 10×3 Price for Trimetazidine tablets p/o 20mg No. 10×3